Clenbuterol, marketed under Dilaterol, Spiropent, Ventipulmin, is a sympathomimetic amine used by people with respiratory disorders such as a decongestant and a bronchodilator. People with chronic breathing problems such as asthma use it as a bronchodilator to make breathing easier. It is most commonly available as hydrochloride, clenbuterol hydrochloride
Clenbuterol The doses for women and men, of course, will be different. Also, different for experienced and beginner athletes.
For men, the average dose is approximately 120 to 140 mg per day.
For women, it is somewhat less – around 80-100 mg per day.
Experienced culturists take medication in stages – in 2 days. According to them, it helps the body to adapt better and improve the effectiveness of steroid action.
The side effects
Athletes who take this medication may experience side effects , such as increased heart rate and blood pressure, insomnia, excessive sweating, nausea, diarrhea, anxiety. Virtually all of these side effects are eliminated using drug with ketotifen. For this reason, it is recommended and is included in course.
The analysis of numerous criticisms about the preparation of the athletes, it can be concluded that it has a good swell defined properties that allow you to burn excess unwanted fat that gives the body a beautiful terrain makes important muscle group more interested or and traced.
In combination with a diet and sports nutrition breakfast for drying the body, a good effect, which is beyond the power of any other drug that can be achieved.
Clenbuterol is approved for use in some countries, free or prescription, as a bronchodilator for asthmatic patients
Weight loss drug
Although often used by bodybuilders during their “cut” cycles, the drug has been more recently known to the general public, particularly through celebrity-use stories by celebrities such as Victoria Beckham, Britney Spears and Lindsay Lohan, for its use not indicated as a weight loss drug, similar to the use of other sympathomimetic amines such as ephedrine, despite the lack of sufficient clinical trials to support or reverse this use.